Cargando…
Role of Preoperative Blockade in Pheochromocytoma–Paraganglioma: A Clinician’s Perspective
Autores principales: | Karlekar, Manjiri P., Memon, Saba S., Bandgar, Tushar R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9162254/ https://www.ncbi.nlm.nih.gov/pubmed/35662759 http://dx.doi.org/10.4103/2230-8210.343877 |
Ejemplares similares
-
(177)Lu-DOTATATE therapy in metastatic/inoperable pheochromocytoma-paraganglioma
por: Kumar Jaiswal, Sanjeet, et al.
Publicado: (2020) -
Metastatic cluster 2-related pheochromocytoma/paraganglioma: a single-center experience and systematic review
por: Kumar, Sandeep, et al.
Publicado: (2021) -
Preoperative Management of Pheochromocytoma and Paraganglioma
por: Fang, Fang, et al.
Publicado: (2020) -
The Utility of (68)Ga-DOTATATE PET/CT in Localizing Primary/Metastatic Pheochromocytoma and Paraganglioma: Asian Indian Experience
por: Jaiswal, Sanjeet Kumar, et al.
Publicado: (2021) -
Preoperative Amlodipine Is More Efficacious Than Prazosin in Preventing Intraoperative Haemodynamic Instability in Pheochromocytoma/Paraganglioma Patients: Interim Analysis of a Pilot Randomized Controlled Study
por: Memon, Saba Samad, et al.
Publicado: (2021)